Results 181 to 190 of about 373,462 (307)
Aspirations to study medicine, perceptions of a good doctor, and their influence on specialty choice among medical students. [PDF]
Nguyen QT +5 more
europepmc +1 more source
Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg +20 more
wiley +1 more source
Intracurricular Factors Influencing Medical Students' Specialty Choice: A Systematic Review. [PDF]
Schoon B, Kötter T.
europepmc +1 more source
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner +14 more
wiley +1 more source
Is There a Relationship Between Medical Student Mistreatment and Specialty Choice and Career Intentions? A Systematic Review. [PDF]
Kaur G +4 more
europepmc +1 more source
Objective Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies.
Anahita Deboo +88 more
wiley +1 more source
Can they blame it on the final? How does medical final exam and other factors shape specialty choice? [PDF]
Filipek K +8 more
europepmc +1 more source
Specialty Choice Stability: Are There Implications for Early Entry Into Residency? [PDF]
Cantone RE +3 more
europepmc +1 more source
Objective The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls.
Chadwick R. Johr +5 more
wiley +1 more source

